299 related articles for article (PubMed ID: 15337704)
1. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis.
Rosenhek R; Rader F; Loho N; Gabriel H; Heger M; Klaar U; Schemper M; Binder T; Maurer G; Baumgartner H
Circulation; 2004 Sep; 110(10):1291-5. PubMed ID: 15337704
[TBL] [Abstract][Full Text] [Related]
2. Statin use for nonrheumatic calcific aortic valve stenosis: a review with meta-analysis.
De Vecchis R; Di Biase G; Esposito C; Ciccarelli A; Cioppa C; Giasi A; Ariano C; Cantatrione S
J Cardiovasc Med (Hagerstown); 2013 Aug; 14(8):559-67. PubMed ID: 23032960
[TBL] [Abstract][Full Text] [Related]
3. Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis?
Parolari A; Tremoli E; Cavallotti L; Trezzi M; Kassem S; Loardi C; Veglia F; Ferrari G; Pacini D; Alamanni F
Heart; 2011 Apr; 97(7):523-9. PubMed ID: 21270077
[TBL] [Abstract][Full Text] [Related]
4. Hydroxymethylglutaryl coenzyme-a reductase inhibitors delay the progression of rheumatic aortic valve stenosis a long-term echocardiographic study.
Antonini-Canterin F; Leiballi E; Enache R; Popescu BA; Roşca M; Cervesato E; Piazza R; Ginghină C; Nicolosi GL
J Am Coll Cardiol; 2009 May; 53(20):1874-9. PubMed ID: 19442887
[TBL] [Abstract][Full Text] [Related]
5. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.
Novaro GM; Tiong IY; Pearce GL; Lauer MS; Sprecher DL; Griffin BP
Circulation; 2001 Oct; 104(18):2205-9. PubMed ID: 11684632
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with statins and angiotensin-converting enzyme inhibitors in degenerative aortic stenosis--an up-date].
Moldovanu CM; Pandele GI; Ambăruş V; Ionescu S
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):964-74. PubMed ID: 20191861
[TBL] [Abstract][Full Text] [Related]
7. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?
Antonini-Canterin F; Popescu BA; Huang G; Korcova-Miertusova R; Rivaben D; Faggiano P; Pavan D; Piazza R; Bolis A; Ciavattone A; Ruggiero A; Nicolosi GL
Ital Heart J; 2005 Feb; 6(2):119-24. PubMed ID: 15819504
[TBL] [Abstract][Full Text] [Related]
8. Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.
Wakabayashi K; Tsujino T; Naito Y; Ezumi A; Lee-Kawabata M; Nakao S; Goda A; Sakata Y; Yamamoto K; Daimon T; Masuyama T
Heart Vessels; 2011 May; 26(3):252-7. PubMed ID: 21063877
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.
Moura LM; Ramos SF; Zamorano JL; Barros IM; Azevedo LF; Rocha-Gonçalves F; Rajamannan NM
J Am Coll Cardiol; 2007 Feb; 49(5):554-61. PubMed ID: 17276178
[TBL] [Abstract][Full Text] [Related]
10. Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?
Newby DE; Cowell SJ; Boon NA
Heart; 2006 Jun; 92(6):729-34. PubMed ID: 16698826
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium.
O'Brien KD; Probstfield JL; Caulfield MT; Nasir K; Takasu J; Shavelle DM; Wu AH; Zhao XQ; Budoff MJ
Arch Intern Med; 2005 Apr; 165(8):858-62. PubMed ID: 15851635
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).
van der Linde D; Yap SC; van Dijk AP; Budts W; Pieper PG; van der Burgh PH; Mulder BJ; Witsenburg M; Cuypers JA; Lindemans J; Takkenberg JJ; Roos-Hesselink JW
Am J Cardiol; 2011 Jul; 108(2):265-71. PubMed ID: 21565321
[TBL] [Abstract][Full Text] [Related]
13. The effect of statins on valve function and calcification in aortic stenosis: A meta-analysis.
Zhao Y; Nicoll R; He YH; Henein MY
Atherosclerosis; 2016 Mar; 246():318-24. PubMed ID: 26828749
[TBL] [Abstract][Full Text] [Related]
14. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis.
Antonini-Canterin F; Hîrşu M; Popescu BA; Leiballi E; Piazza R; Pavan D; Ginghină C; Nicolosi GL
Am J Cardiol; 2008 Sep; 102(6):738-42. PubMed ID: 18773999
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function.
O'Brien KD; Zhao XQ; Shavelle DM; Caulfield MT; Letterer RA; Kapadia SR; Probstfield JL; Otto CM
J Investig Med; 2004 Apr; 52(3):185-91. PubMed ID: 15222408
[TBL] [Abstract][Full Text] [Related]
16. The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality.
Ardehali R; Leeper NJ; Wilson AM; Heidenreich PA
J Heart Valve Dis; 2012 May; 21(3):337-43. PubMed ID: 22808835
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy to prevent progression of calcific aortic stenosis.
Rajamannan NM; Otto CM
Circulation; 2004 Sep; 110(10):1180-2. PubMed ID: 15353511
[No Abstract] [Full Text] [Related]
18. Letter regarding article by Rosenhek et al, "statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis".
Routledge HC; Townend JN
Circulation; 2005 May; 111(17):e274-5; author reply e274-5. PubMed ID: 15867188
[No Abstract] [Full Text] [Related]
19. Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke.
Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):370-7. PubMed ID: 22023326
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA;
N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
